Difference between revisions of "Citalopram-mianserine"

From Psychiatrienet
Jump to: navigation, search
Line 3: Line 3:
 
| to = mianserine  
 
| to = mianserine  
 
| stop =  
 
| stop =  
* Gradually reduce dosage of citalopram/escitalopram to a maximum of 20 mg/ day resp. 10 mg/day, when this dosage is respectively > 20 mg/day and > 10 mg/day.  
+
* '''Before day 0:''' gradually reduce dosage of citalopram/escitalopram to a maximum of 20 mg/ day resp. 10 mg/day, when this dosage is respectively > 20 mg/day and > 10 mg/day.
* When a dosage of 20 mg/day, resp. 10 mg/day, is reached, stop administration.
+
* '''Day 1:''' reduce dosage of citalopram/escitalopram to a maximum of 10 mg/ day resp. 5 mg/day.
 
| start =  
 
| start =  
* No wash-out period is needed.
+
* '''Day 1:''' simultaneously start mianserine in a low dosage of 30 mg/day.
* Start mianserine the next day in low dosage of 30 mg/day.
+
* '''Day 8:''' stop administration of citalopram/escitalopram and continue administration of mianserine.
 
| info =  
 
| info =  
 
* The same applies to [[escitalopram]].
 
* The same applies to [[escitalopram]].
 
}}
 
}}

Revision as of 13:37, 4 September 2009

Citalopram
Type Antidepressant
Group SSRI
links
ATC-code N06AB04
Medscape Citalopram
PubChem 2771
PubMed Citalopram
Kompas (Dutch) citalopram
Wikipedia citalopram
Mianserine
Type Antidepressant
Group other
links
PubChem 4184
PubMed Mianserine
Kompas (Dutch) Mianserine
Wikipedia Mianserine

Switch medication from citalopram to mianserine.[1] [2]

Nietinrijdenbord.png Stop citalopram
  • Before day 0: gradually reduce dosage of citalopram/escitalopram to a maximum of 20 mg/ day resp. 10 mg/day, when this dosage is respectively > 20 mg/day and > 10 mg/day.
  • Day 1: reduce dosage of citalopram/escitalopram to a maximum of 10 mg/ day resp. 5 mg/day.
Eenrichtingbord.png Start mianserine
  • Day 1: simultaneously start mianserine in a low dosage of 30 mg/day.
  • Day 8: stop administration of citalopram/escitalopram and continue administration of mianserine.
Infobord.png More information
  1. Switches are based on literature references on this page and expert opinions of the authors. The authors have used pharmacokinetic and receptor affinity properties to determine the switch schedules
  2. Stahl, S. M. (2013). Stahl's essential psychopharmacology: Neuroscientific basis and practical applications (4th ed.). Cambridge University Press.
The editors of psychiatrienet.nl take the greatest care to provide up-to-date and accurate information on this site. Nevertheless, mistakes and omissions cannot be entirely excluded. No rights devolve from the information provided. The editors and other providers of information to this site accept no responsibility for the content of this site or for the information provided therein; neither do they accept responsibility for possible damages which may derive from the use of the information on this site or from the linked sites. The editorial board accepts no responsibility for the content of the (linked) sites, for access to them, or for the products and services on these sites, nor for the occurrence of errors, viruses, and/or disruptions in service.